Laminaria

Laminaria: A Comprehensive Encyclopedic Reference

1. Identity: Taxonomy, Nomenclature, and Natural Sources

Laminaria is a genus of large brown macroalgae (class Phaeophyceae) belonging to the order Laminariales, commonly referred to as kelp. The genus belongs to the group of brown algae, also known as phaeophytes, and its members are recognized chiefly by their wide, long, ribbon-like blades with a leathery texture that can reach several meters in length. The genus encompasses numerous species, the most medically and commercially significant of which are:

• Laminaria japonica (synonym Saccharina japonica) — the dominant species in East Asian aquaculture and traditional medicine, known as kombu in Japanese and kunbu or haidai in Chinese.
• Laminaria digitata — a native North Atlantic species, often called "oarweed," widely harvested in Ireland, France, and the United Kingdom.
• Laminaria hyperborea — found primarily in the northeastern Atlantic, an important source of alginates for industry.
• Laminaria saccharina (synonym Saccharina latissima, "sugar kelp") — distributed across the North Atlantic and North Pacific.

Laminaria is frequently found in the cold and temperate waters of the Atlantic and North Pacific, growing at depths typically between 8 and 39 meters, attached to rocky substrates. The alga usually grows on rocky substrates at depths of 2 to 10 meters and can grow up to 3 meters in length.

Common synonyms and trade names include Brown Algae, Brown Seaweed, Kelp, Kombu, Laminaire, Limu, and Makombu Thallus; the part most typically used in commerce and medicine is the stem (stipe) and thallus (blade).

In pharmacopeial and dietary supplement contexts, the dried thallus is sold as kelp powder (registered as Thallus laminariae). A Standard Reference Material (SRM) of seaweed, SRM 3232 Kelp Powder (Thallus laminariae), has been developed to support food and dietary supplement measurements in compliance with the Food Safety Modernization Act (FSMA) and the Dietary Supplement Health and Education Act of 1994 (DSHEA).

Common Commercial Forms and Preparations

• Dried whole thallus (used in cooking and as a raw material for extraction)
• Powdered kelp (encapsulated or in bulk for supplementation)
• Standardized extracts (targeting fucoidan, laminarin, or alginate content)
• Alginic acid / sodium alginate (purified polysaccharide derived from the cell wall, used in food, pharmaceutical, and nutraceutical industries)
• Laminaria "tents" (dried, compressed stipe material used as clinical osmotic cervical dilators)
• Fermented preparations (particularly fermented L. japonica used in some clinical studies)

Seaweeds have a long history of use as food, as flavouring agents, and find use in traditional folk medicine; seaweed products range from food, feed, and dietary supplements to pharmaceuticals, and from bioenergy intermediates to materials.

2. Traditional and Historical Use

East Asia

Laminaria has been used in traditional Chinese medicine for centuries and is listed in the Chinese pharmacopeia; in general, it is considered a cold, salty herb, prescribed to cleanse heat, resolve phlegm, and soften and disperse hard accumulations such as goiters. It is often used to control edema, as an expectorant and antitussive, and as a remedy for testicular pain and swelling.

Seaweeds have a long history of use as food and medicine worldwide, including in China, Japan, Iceland, and the Mediterranean. Kombu has been eaten as a food in Japan for at least several hundred years, with one of the earliest mentions appearing in the Shoku Nihongi, an imperially commissioned Japanese history text, circa 797 AD.

Laminaria arrived in China from Hokkaido, Japan in the late 1920s, after which it was cultivated on a much larger industrial scale.

In traditional Chinese medicine (TCM), L. japonica — known as kun bu (昆布) — was employed primarily in the treatment of goiter (enlarged thyroid), scrofula, and other "phlegm-heat accumulations." Laminaria is a traditional Chinese medicinal herb used to soften and dissolve phlegm, promote diuresis and ease edema. Traditional practitioners also recognized it as useful in managing swollen lymph nodes and orchitis.

Japan

In Japan, kombu has been an indispensable culinary ingredient and folk remedy for centuries. It is used as the foundation of dashi (stock) in Japanese cuisine and was historically consumed to support general vitality and thyroid health, and to reduce swelling and goiter in coastal communities where iodine was abundant through dietary seaweed. The traditional Japanese diet includes an average daily intake of more than 2 g of kombu.

European and Other Traditions

In 19th-century Western medicine, the dried stipe of Laminaria was first formally adopted as a clinical tool for cervical dilation. Laminaria has been used traditionally as a hygroscopic cervical dilator and inducer of labor or cervical preparation for dilation and evacuation, and commercial products are available for this purpose. This clinical application — distinct from dietary or herbal use — dates to at least the early 1970s in the modern obstetric and gynecological literature. Due to its great content of iodine and vitamins, it has historically been used in the form of powder for the treatment and prophylaxis of atherosclerosis and goiter.

It has also been recommended in cases of chronic constipation as an eccoprotic, with a dose of 2–3 g of powder in 150 ml of water taken nocturnally, as well as for the improvement of metabolic processes and in cases of gout.

3. Key Constituents and Active Compounds

Laminaria species contain a chemically diverse array of bioactive compounds. The major constituent classes are described below.

3.1 Iodine

Iodine is arguably the most clinically relevant constituent of Laminaria. The iodine concentration of seaweed varies dramatically depending on species, geographic origin, processing methods, and preparation. Brown seaweeds such as kelp (Laminaria species) and kombu may contain iodine concentrations ranging from several hundred micrograms to several thousand micrograms per gram of dry weight. In L. hyperborea blades, iodine concentrations of approximately 7,340 mg/kg dry weight have been analytically measured. Laminaria contains iodine (around 3%) in the form of iodine-organic compounds and iodides, as well as vitamins A, B1, B2, B12, C, and folic acid.

3.2 Polysaccharides

Algal-derived polysaccharides have gained much interest owing to their abundance as the main cell wall constituent as well as their unique physicochemical and biological properties. Marine algal polysaccharides, including laminarin, fucoidan, and alginate, have been widely explored for food, pharmaceutical and biomedical applications.

Laminarin is the primary storage polysaccharide in Laminaria. Unlike plants where the main storage compound is starch, chromists store laminarin (hence the name Laminaria) in the form of chains of mannitol and glucose, and the organelles used for the storage are pyrenoids. Structurally, laminarin is a β-glucan composed of glucose linked by β-1,3 and β-1,6 glycosidic bonds. It demonstrates strong biocompatibility and low toxicity. Laminarin has exhibited potential in cancer therapy by inducing apoptosis. Research has also shown that laminarin's efficacy extends to suppressing the compensatory glycolytic switch and ameliorating mitochondrial dysfunction by restoring the mitochondrial membrane potential and regulating genes involved in mitochondrial respiration; collectively these results suggest that laminarin ameliorates microglial inflammation and metabolic dysregulation by activating the SIRT1-AMPK axis to restore metabolic homeostasis.

Fucoidan is a sulfated fucose-rich polysaccharide found in the cell walls of brown algae including Laminaria japonica. Fucoidans, discovered in 1913, are fucose-rich sulfated polysaccharides extracted mainly from brown seaweed. These versatile and nontoxic marine-origin heteropolysaccharides have a wide range of favorable biological activities, including antitumor, immunomodulatory, antiviral, antithrombotic, anticoagulant, antioxidant, and lipid-lowering activities. Fucoidan has been found to exhibit antiangiogenetic and antitumor properties through the interaction of sulfate groups with VEGF; negatively charged groups on fucoidan interact with VEGF165 and block its recognition and binding to the receptor.

Alginate (Alginic Acid / Sodium Alginate) is the primary structural polysaccharide of the Laminaria cell wall. Apart from laminarin in pyrenoids, the cell walls of chromists contain algin, a gum used as a thickener and emulsifier in the food and cosmetics industry. Alginate forms viscous gels in the gastrointestinal tract and is the constituent primarily responsible for the satiety-promoting and postprandial glucose-moderating effects observed in human studies.

3.3 Minerals

Kelp has been characterized for nutritional minerals including arsenic species, isomers of vitamin K1, and toxic elements; it is a rich source of vitamins and minerals and an excellent source of dietary iodine. Kelp also contains a large amount of arsenic. Certified values have been issued for As, Ca, Cd, Cr, Cu, Fe, Hg, I, K, Mg, Mn, Mo, Na, Pb, and Zn.

3.4 Other Bioactive Constituents

Laminaria also contains mannitol, alginic acid, vitamins A, B1, B2, B12, C, and folic acid, as well as sodium, calcium, magnesium, copper, cobalt, bromine salts, traces of arsenic, and potassium salts. The essential oil fraction of L. japonica, while a minor component, has also been studied: L. japonica essential oil contains 21 volatile compounds comprising 99.76% of the total volume, primarily tetradecanoic acid (51.75%), hexadecanoic acid (16.57%), (9Z,12Z)-9,12-octadecadienoic acid (12.09%), and (9Z)-hexadec-9-enoic acid (9.25%).

3.5 Mechanisms of Action: Overview

The established or proposed mechanisms of action of Laminaria and its constituents include:

• Thyroid iodine provision: Iodine is incorporated into thyroid hormones (T3 and T4); high iodine load from Laminaria can acutely suppress or stimulate thyroid function via the Wolff-Chaikoff effect.
• Immune modulation and antitumor activity (fucoidan): Among the anticancer mechanisms of fucoidan are cell cycle arrest, apoptosis evocation, and stimulation of cytotoxic natural killer cells and macrophages.
• Anticoagulant / antithrombotic (fucoidan): Sulfate groups in fucoidan structurally mimic heparin, interacting with coagulation cascade enzymes.
• Anti-inflammatory (laminarin and fucoidan): Many research studies have reported the anti-inflammatory effects of Laminaria species; the anti-inflammatory mechanisms include the production of prostaglandins and the inhibition of inflammatory reactions in enzyme synthesis.
• Glycemic modulation (alginate, laminarin): Viscous gel formation in the gut slows glucose absorption; laminarin shows α-glucosidase inhibitory activity. Laminarins showed greater α-glucosidase inhibitory effects compared to fucoidans.
• Antioxidant activity: Fucoidans have diverse biological activities, including anticoagulant, antioxidant, and antitumor activities, depending on their physicochemical properties; the antioxidant capacity of fucoidan is influenced by its molecular weight and degree of sulfation.
• Cervical dilation (osmotic): The stipe of Laminaria is hygroscopic and can swell 3 to 5 times its original diameter within 12 to 24 hours when placed in the cervical canal, inducing mechanical dilation.

4. Scientific Evidence by Area of Use

4.1 Thyroid Function and Iodine Supply

Thyroid function demonstrates a nonlinear, U-shaped relationship with iodine intake, in which both deficiency and excess may precipitate dysfunction.

The most rigorously designed human clinical study of L. japonica on thyroid function is a clinical trial by Miyai et al. (2008), published in Endocrine Journal. The effect of ingesting seaweed "Kombu" (Laminaria japonica) on thyroid function was studied in normal Japanese adults. Ingesting 15 and 30 g of Kombu (iodine contents: 35 and 70 mg) daily for a short term (7–10 days) significantly increased serum thyrotropin (TSH) concentrations, exceeding the normal limits in some subjects. The serum free thyroxine (FT4) and/or free triiodothyronine (FT3) concentrations were slightly decreased within normal limits. This indicates that even short-term high-dose intake of Laminaria can induce subclinical hypothyroidism via iodine excess (the Wolff-Chaikoff effect) in otherwise healthy adults.

A separate randomized, double-blind, placebo-controlled study (Aoe et al., 2021, published in Marine Drugs, n=50) investigated whether supplementation with iodine-reduced kelp (Laminaria japonica) powder decreases body fat in overweight Japanese subjects with BMI ≥25 and <30 kg/m². Subjects were assigned to consume thirty tablets per day containing either iodine-reduced kelp powder (test, 6 g kelp powder corresponding to 3 g alginate/day) or kelp-free powder (placebo) for 8 weeks. Serum thyroid hormone concentrations did not increase after 1.03 mg/day of iodine supplementation through kelp intake. This contrasts with the acute high-dose study above and underscores the relevance of iodine dose and duration.

Evidence strength: There is good-quality clinical evidence that Laminaria acutely alters thyroid parameters through its iodine load. The effect is dose-dependent and species-specific. Evidence for beneficial thyroid support in clinical hypothyroidism from oral Laminaria supplementation alone is not well established by controlled trials.

4.2 Cervical Ripening and Dilation (Obstetric and Gynecological Use)

The use of laminaria tents for cervical dilation is the most thoroughly clinically documented application of Laminaria in conventional medicine. Laminaria tents are used in obstetrics and gynecology for dilatation and/or ripening of the cervix; they are effective in labor induction, abortion, endometrial biopsy, treatment of cervical stenosis, and difficulty in inserting and removing intrauterine pessaries.

Dilators are made from the dried stems of laminaria seaweeds. When dried and rounded into a stick-like shape, the dilators are approximately 6 cm (2.5 inches) long with a diameter of 0.3 to 0.5 cm. A strong thread is attached to one end, and a collar prevents migration into the uterus. The stem is hygroscopic and can swell 3 to 5 times its original diameter within 12 to 24 hours.

A key randomized clinical trial (Munsick et al., 1995, Obstetrics & Gynecology, n=93) compared thick laminaria tents to two synthetic osmotic devices (Hypan and anhydrous magnesium sulfate) for 6 hours before abortion in subjects 7–14 weeks pregnant. Forcible dilation was easiest with thick laminaria tents and most difficult with magnesium sulfate devices. All devices provided safe cervical dilation and softening, but thick tents were most effective.

A Cochrane-referenced body of evidence synthesized in Drugs.com's clinical monograph notes that in trials of laminaria versus placebo, no evidence exists of increased risk of cesarean delivery; rates of cesarean delivery were the same for laminaria versus oxytocin and for laminaria versus extra-amniotic infusion. In trials versus prostaglandins, the risk of cesarean delivery was the same for both groups; however, laminaria caused less hyperstimulation with fetal heart rate changes. However, more recent trials evaluating laminaria versus misoprostol and mifepristone found similar efficacy but showed an increase in cost, induction times, and pain associated with laminaria.

Cervical priming can be achieved with osmotic dilators or pharmacological agents. The advantages of osmotic dilators such as laminaria are their ability to produce wide cervical dilation.

Evidence strength: Strong. This is the most evidence-supported use of Laminaria in clinical medicine, with multiple randomized trials and inclusion in clinical practice guidelines for gynecological procedures.

4.3 Postprandial Blood Glucose and Glycemic Control

A meta-analysis of brown seaweed consumption identified that in subgroup analysis, seaweeds such as Laminaria digitata, Undaria pinnatifida, Ascophyllum nodosum, and Fucus vesiculosus were found to be more effective at improving blood glucose levels than control treatments, with a high dose (1000 mg or more) being more beneficial than a low dose.

Human studies demonstrating postprandial blood glucose reduction effects through supplementation with seaweed from the Laminaria genus have been reported. A crossover trial (Georg Jensen 2012, n=19 healthy Danish subjects) evaluated a 3% alginate extract beverage from Laminaria hyperborea and Lessonia trabeculata. A 4-way double-blind, placebo-controlled, crossover trial evaluated the effects of a preload low- and high-volume 3% alginate extract beverage on satiety, energy intake, and gastric emptying rate. Satiety and fullness were significantly increased, while hunger and prospective food intake were significantly decreased with the high-volume alginate treatment versus high-volume control. A significant reduction in energy intake was documented for the low-volume, but not the high-volume, treatment. High-volume alginate preload also resulted in a significant (40%) reduction in glucose response.

A comprehensive narrative review of randomized controlled trials (RCTs) published in 2023 found that out of 25 RCTs reviewed, findings revealed limited yet encouraging evidence for effects of seaweed on blood glucose metabolism, blood pressure, anthropometric measures, and, to a lesser extent, blood lipids. A 2023 meta-analysis concluded that brown seaweeds including Laminaria digitata are effective in regulating postprandial blood glucose, with beneficial effects becoming noticeable at a daily dosage exceeding 1000 mg and a consumption period of more than 12 weeks.

Evidence strength: Preliminary to moderate. Acute postprandial glucose reduction from alginate is relatively well-supported in small human crossover studies. Effects on HbA1c, fasting glucose, and insulin resistance in clinical populations require larger, longer-term RCTs for confirmation.

4.4 Body Composition and Weight

In the randomized, double-blind study by Aoe et al. (2021, Marine Drugs, n=50, 8 weeks), body fat percentage was significantly decreased in male subjects from the test group compared with the placebo group. The same tendency was observed for body weight (p=0.065) and BMI (p=0.072) in male subjects. No significant changes in anthropometric measurements or visceral fat area were observed in female subjects. The study's limitations include a small sample size, and a larger study is planned for the future.

Pre-prandial intake of sodium alginate by normal, overweight and obese individuals showed reduced mean daily intake of sugar, carbohydrate, protein, fat and saturated fat as well as decreased mean daily energy intake by 7%, indicating a potentially beneficial role of the gelling properties of sodium alginate formulation in managing obesity.

Evidence strength: Preliminary. Current RCT evidence for body fat reduction is limited by small samples, short durations, and sex-specific heterogeneity. The mechanism via alginate-induced satiety is plausible and supported by physiological studies, but weight loss efficacy in larger populations is not established.

4.5 Antitumor and Anticancer Potential

The anticancer research on Laminaria constituents — primarily fucoidan and laminarin — is extensive at the preclinical level but sparse in human clinical trials.

Fucoidan, a sulfated fucose-based polysaccharide from brown algae, has gained attention as an antitumor drug owing to its anticancer effects against multiple cancer types. Among the anticancer mechanisms of fucoidan are cell cycle arrest, apoptosis evocation, and stimulation of cytotoxic natural killer cells and macrophages. Fucoidan also protects against toxicity associated with chemotherapeutic drugs and radiation-induced damage. The synergistic effect of fucoidan with existing anticancer drugs has prompted researchers to explore its therapeutic potential.

For laminarin, laminarin has exhibited potential in cancer therapy by inducing apoptosis. In a study using 3D tumor spheres across different cancer cell lines, the crude laminarin and fucoidan samples showed higher cytotoxic activity; 3D tumor spheres using different cancer cell lines showed significantly higher resistance to bioactive compounds compared to 2D monolayer cells. This is a critical finding that highlights the limitation of conventional 2D in vitro assays for predicting clinical efficacy.

Regarding human data, a human study reported that 4 of 17 patients taking approximately 6 g fucoidan per day had diarrhea, and their condition was stable after discontinuing fucoidan intake. This was primarily a safety observation rather than an efficacy trial.

It was generally believed that large-molecular-weight fucoidan could not be absorbed by the human intestine due to the lack of the corresponding digestive enzymes; as a result, the mechanism of antitumor effect of fucoidan by oral administration remains unclear.

Evidence strength: Preclinical only for most claims. In vitro and animal model data are substantial and mechanistically plausible, but human clinical trial evidence for anticancer efficacy of Laminaria-derived compounds is absent or very preliminary. No regulatory body has approved any Laminaria compound as a cancer treatment.

4.6 Antioxidant and Anti-inflammatory Activity

Crude laminarin and fucoidan samples exhibited higher antioxidant activity (p < 0.05) than the purified samples and commercial standards, as measured by DPPH and ferric-reducing antioxidant power (FRAP) assays. Similarly, crude extracts showed stronger anti-inflammatory and antidiabetic effects compared to the purified samples. These findings are from in vitro and cell-based assays.

The antioxidant and anti-inflammatory characteristics of fucoidan and laminarin suggest applications in managing chronic inflammatory conditions and neurodegenerative diseases.

Evidence strength: Primarily in vitro and preclinical. Human evidence for clinically meaningful antioxidant or anti-inflammatory effects from oral Laminaria supplementation is not yet demonstrated through large controlled trials.

4.7 Neurodegeneration and Cognitive Health

Initial data support benefit for age-related cognitive and physical neurodegeneration with consumption of fermented Laminaria; fermented Laminaria japonica 1.5 g/day was consumed for 6 weeks for age-related neurodegeneration. However, clinical trials specifically dedicated to this application remain limited.

Research with β-glucans (the class to which laminarin belongs) in animal models has explored gut-brain axis mechanisms. Laminarin's efficacy has extended to suppressing the compensatory glycolytic switch and ameliorating mitochondrial dysfunction by restoring the mitochondrial membrane potential and regulating genes involved in mitochondrial respiration; these results suggest that laminarin ameliorates microglial inflammation and metabolic dysregulation by activating the SIRT1-AMPK axis to restore metabolic homeostasis, positioning laminarin as a promising therapeutic candidate for neuroinflammatory disorders.

Evidence strength: Preliminary. Mechanistic preclinical data are intriguing, but high-quality human RCTs are lacking. This area of research is in early stages.

4.8 Lipid Metabolism

In rat-based research, sodium alginate isolated from Laminaria angustata and low-molecular-weight sodium alginates (molecular weights 10, 50, and 100 kDa) were studied for their effects on cholesterol excretion and glucose tolerance; the natural sodium alginate (AG-270) and certain low-molecular-weight alginates (AG-5 and AG-10) enhanced cholesterol excretion into faeces. Human evidence is more limited; the strong-gelling property of alginate consumed as a drink by volunteers selectively restored the uptake of glucose and cholesterol in overweight and obese individuals to levels normally observed in healthy subjects.

Evidence strength: Preliminary. Animal and small human mechanistic studies support plausibility, but RCT evidence for meaningful lipid reduction in clinical populations is insufficient.

4.9 Antibacterial Activity

The essential oil of L. japonica at a concentration of 25 mg/paper disc exerted high antibacterial activity against S. aureus (11.5 ± 0.58 mm inhibition zone) and B. cereus (10.5 ± 0.57 mm inhibition zone), but no inhibition of E. coli O157:H7.

Evidence strength: In vitro only. No human clinical evidence for antibacterial applications of Laminaria preparations.

5. Body Systems and Health Areas

• Endocrine system (thyroid): Primary iodine source; relevant to both deficiency prevention and excess-induced thyroid dysfunction.
• Gynecological / obstetric: Cervical ripening and dilation via hygroscopic mechanical action — clinically established use.
• Gastrointestinal system: Alginate forms viscous gels in the gut, promoting satiety and slowing absorption of glucose and lipids. Seaweed samples can also relieve symptoms related to human gastrointestinal disorders.
• Immune system: Fucoidan modulates NK cell activity, macrophage polarization, and cytokine expression in preclinical models.
• Cardiovascular / metabolic: Potential modulation of postprandial glucose, cholesterol absorption, and blood pressure via fiber-based mechanisms.
• Nervous system: Emerging preclinical research on anti-neuroinflammatory and neuroprotective effects of laminarin via the SIRT1-AMPK axis.
• Oncology: Preclinical anticancer activity via fucoidan and laminarin; no clinical approval.

6. Dosage Forms and Reported Dosages

The following dosages are reported as used in specific identified studies and should not be construed as recommendations:

• Oral kelp powder (supplementation): Seaweed is generally considered safe at doses up to 1000 mg/day, with 200–500 mg one to two times per day being a commonly cited dose range.
• Traditional Japanese dietary intake: The traditional Japanese diet includes an average daily intake of more than 2 g of kombu.
• Kombu in thyroid study: 15 and 30 g of kombu (iodine contents 35 and 70 mg) daily for a short term of 7–10 days were the doses used by Miyai et al. (2008).
• Iodine-reduced kelp for body composition: 6 g kelp powder per day (corresponding to 3 g alginate/day), consumed as thirty tablets (10 tablets 3 times/day) for 8 weeks.
• Alginate beverage for glucose/satiety: A preload low- and high-volume 3% alginate extract beverage from Laminaria hyperborea and Lessonia trabeculata was tested in 19 healthy Danish subjects.
• Fermented L. japonica for neurodegeneration: 1.5 g/day consumed for 6 weeks.
• Fucoidan (human safety study): Approximately 6 g fucoidan per day was used in a 17-patient human study.
• Laminaria cervical tents: Dried stems are rounded into a stick-like shape, approximately 6 cm (2.5 inches) long with a diameter of 0.3 to 0.5 cm. Multiple tents are placed simultaneously depending on clinical need.
• Traditional use (constipation): 2–3 g of powder in 150 ml of water, administered nocturnally, has been cited in historical Russian medical literature.
• Effective dose for blood glucose (meta-analytic finding): Beneficial effects have been noted with a daily dosage exceeding 1000 mg and a consumption period of more than 12 weeks.

7. Safety Considerations

7.1 Iodine Excess and Thyroid Dysregulation

While sea vegetables can provide dietary iodine, the assumption that natural sources are inherently safe overlooks the substantial variability in iodine content and the potential for excessive exposure. The iodine concentration of seaweed varies dramatically depending on species, geographic origin, processing methods, and preparation. The documented clinical outcome of high-dose Laminaria intake — significant elevation of TSH exceeding normal limits — confirms that ingesting 15 and 30 g of Kombu daily for 7–10 days can cause serum TSH concentrations to exceed normal limits in some subjects. This risk is particularly relevant for individuals with pre-existing thyroid disease, especially Hashimoto's thyroiditis, where maintaining iodine intake within recommended ranges while avoiding high-dose supplementation represents a prudent, evidence-aligned approach.

7.2 Heavy Metals and Potentially Toxic Elements

The concentrations of heavy metals in edible seaweed are generally below toxic levels; however, levels of arsenic (As), cadmium (Cd), and copper (Cu) may exceed toxic levels. The EFSA conducted a formal assessment: EFSA assessed the relevance of seaweed and halophyte consumption to the dietary exposure to heavy metals (arsenic, cadmium, lead and mercury) and the iodine intake in the European population. The highest mean occurrence levels were reported for iodine; among the heavy metals, the highest mean was for arsenic, in particular for total arsenic but also in few samples for inorganic arsenic, and cadmium. Overall, the highest mean levels were reported for brown seaweeds, followed by red and green seaweeds.

Laminaria digitata accumulates the highest amounts of iodine, though the same species also has the highest levels of arsenic among seaweed species tested. Kelp can accumulate arsenic from seawater, with Laminaria digitata showing the highest levels among seaweed species tested. This is a particular concern for pregnant and nursing women (arsenic crosses the placenta), long-term kelp supplement users, and people consuming whole kelp products rather than standardized extracts.

In Laminaria hyperborea, concentrations of arsenic at 56.29 mg/kg dry weight and cadmium at 0.596 mg/kg dry weight have been analytically documented, alongside iodine at 7,340 mg/kg dry weight.

7.3 Anticoagulant Interactions (Fucoidan)

Daily administration of 300 mg/kg body weight fucoidan extracted from Laminaria japonica to rats for over 180 days did not prompt any detrimental side effects; nonetheless, a higher dose of 900–2500 mg/mL caused coagulopathy and noticeably reduced blood clotting time. This is an animal-model finding, but it raises the concern that very high fucoidan intake may potentiate anticoagulant medications (e.g., warfarin, heparin) in humans. Formal human drug-interaction data are not well established.

7.4 Hypersensitivity and Anaphylaxis

There is a risk of laminaria dilators becoming trapped and fragmenting; cases of hypersensitivity, including anaphylaxis, have been reported.

7.5 Septic Complications from Laminaria Tents

Laminaria tents are commonly used to aid cervical dilation in gynecological procedures, but there are limited data available on their potential risks and the severity of possible complications. The use of antibiotic prophylaxis can vary among physicians and is not well documented in the literature. A documented case report describes a healthy 27-year-old woman who developed septic shock with multi-organ failure following the use of two laminaria tents for dilation and curettage; laminaria tents were in an unusual state of disintegration upon removal, and the patient subsequently developed fever and pelvic pain, with positive inflammatory markers, hypoxemic respiratory failure, and disseminated intravascular coagulation. A computed tomography scan revealed multiple septic emboli and blood cultures grew Staphylococcus aureus.

7.6 Gastrointestinal Effects

A human study reported that 4 of 17 patients taking approximately 6 g fucoidan per day had diarrhea, and their condition was stable after discontinuing fucoidan intake.

7.7 Pregnancy (Dietary Supplement Use)

Use of dietary laminaria supplementation is contraindicated during pregnancy. Laminaria dilators have been used clinically to dilate the cervix and to induce labor in abortions. The combination of potential cervical effects and high iodine and arsenic exposure makes unsupervised supplemental use during pregnancy a documented concern.

7.8 Iodine Bioavailability

Brown algae have a high iodine content that, upon intake, may exceed the recommended dietary intake level, but iodine bioavailability has been reported to be lower than from potassium iodide and highly depends on algae species.

7.9 Quality and Labeling Concerns

A relatively high variation in heavy metals and iodine levels was found across seaweed samples even within species, underscoring the importance of using analytically verified, standardized preparations. Standard Reference Material SRM 3232 (Kelp Powder) will be useful for method validation and quality assurance in measurements of nutritional and toxic contents of kelp in diet and dietary supplements.

References

• Patra JK, Das G, Baek K-H. Chemical Composition and Antioxidant and Antibacterial Activities of an Essential Oil Extracted from an Edible Seaweed, Laminaria japonica L. Molecules. 2015. PMC6332342.
• McHugh DJ. Aquaculture Production of the Brown Seaweeds Laminaria digitata and Macrocystis pyrifera: Applications in Food and Pharmaceuticals. PMC7957606.
• ScienceDirect Topics: Laminaria — Overview.
• Miyai K, Tokushige T, Kondo M; Iodine Research Group. Suppression of thyroid function during ingestion of seaweed "Kombu" (Laminaria japonica) in normal Japanese adults. Endocr J. 2008;55(6):1103-1108. PMID: 18689954.
• Aoe S et al. Effects of Daily Kelp (Laminaria japonica) Intake on Body Composition, Serum Lipid Levels, and Thyroid Hormone Levels in Healthy Japanese Adults: A Randomized, Double-Blind Study. Mar Drugs. 2021;19(7):352. PMC8307228.
• Biological Properties and Health-Promoting Functions of Laminarin: A Comprehensive Review of Preclinical and Clinical Studies. PMC9780867.
• Investigation of Biological Activity of Fucoidan and Laminarin as Bioactive Polysaccharides from Irish Brown Macroalgae. PubMed 39682687.
• Investigation of Biological Activity of Fucoidan and Laminarin as Bioactive Polysaccharides from Irish Brown Macroalgae. PMC11640187.
• The biomedical frontier of fucoidan and laminarin: emerging insights. PubMed 40588364.
• The Therapeutic Potential of the Anticancer Activity of Fucoidan: Current Advances and Hurdles. PMC8151601.
• Immunopotentiating Activity of Fucoidans and Relevance to Cancer Immunotherapy. PMC9961398.
• Fucoidan's Molecular Targets: A Comprehensive Review. PMC10820140.
• The anti-cancer effects of fucoidan: a review of both in vivo and in vitro investigations. PMC7206694.
• Ten Years of Research on Fucoidan and Cancer: Focus on Its Antiangiogenic and Antimetastatic Effects. PMC10223425.
• Drugs.com. Laminaria Uses, Benefits & Dosage. Clinical Monograph (medically reviewed, last updated May 18, 2026).
• [Clinical application of the natural cervical dilatators (Laminaria) in obstetrics and gynecology]. PubMed 21913571.
• Munsick RA et al. Cervical Dilation From Laminaria Tents and Synthetic Osmotic Devices. Obstet Gynecol. 1995;86(6):931-935.
• Use of laminarias for osmotic dilation of the cervix in gynecological brachytherapy applications. PubMed 9869228.
• Laminaria tent use for dilation, extraction, and curettage leading to septic shock: a case report. PMC12366359.
• Dujardin B et al. Dietary exposure to heavy metals and iodine intake via consumption of seaweeds and halophytes in the European population. EFSA / PMC9887633.
• Development of a Kelp Powder (Thallus laminariae) Standard Reference Material. PMC6013078.
• Noriega-Fernández E et al. Innovative Ultrasound-Assisted Approaches towards Reduction of Heavy Metals and Iodine in Macroalgal Biomass. Foods. 2021;10(3):649. PMC8003320.
• Iodine Bioavailability and Accumulation of Arsenic and Cadmium in Rats Fed Sugar Kelp (Saccharina latissima). PMC9777903.
• European Society of Medicine. Iodine and Thyroid Health: Myths and Clinical Insights. Narrative review, 2026.
• MDPI Cells. Investigation of Biological Activity of Fucoidan and Laminarin as Bioactive Polysaccharides from Irish Brown Macroalgae. 2024.
• Seaweed-derived laminarin and alginate as potential chemotherapeutical agents: An updated comprehensive review. ScienceDirect, 2024.
• Brown Seaweed Consumption as a Promising Strategy for Blood Glucose Management: A Comprehensive Meta-Analysis. Nutrients. 2023;15(23):4987.
• Potential Bioactive Compounds from Seaweed for Diabetes Management. PMC4557030.
• Effects of whole seaweed consumption on humans: current evidence from randomized-controlled intervention trials, knowledge gaps, and limitations. PMC10399747.
• Physicochemical Properties of the Soluble Dietary Fiber from Laminaria japonica and Its Role in the Regulation of Type 2 Diabetes Mice. PMC8779286.
• Effects of soluble sodium alginate on cholesterol excretion and glucose tolerance in rats. PubMed 8941868.
• Restorative Medicine. Oarweed (Laminaria digitata) Monograph.
• Antioxidant and anticancer properties of fucoidan isolated from Saccharina japonica brown algae. Scientific Reports. 2025.